Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Cash from Investing Activities (2018 - 2025)

TransMedics (TMDX) has 8 years of Cash from Investing Activities data on record, last reported at -$15.5 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 14.02% year-over-year to -$15.5 million; the TTM value through Dec 2025 reached -$59.3 million, up 54.18%, while the annual FY2025 figure was -$59.3 million, 54.18% up from the prior year.
  • Cash from Investing Activities reached -$15.5 million in Q4 2025 per TMDX's latest filing, down from -$7.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $24.7 million in Q3 2022 and bottomed at -$149.8 million in Q3 2023.
  • Average Cash from Investing Activities over 5 years is -$14.9 million, with a median of -$5.2 million recorded in 2022.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 478.73% in 2022, then crashed 4665.05% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at $10.0 million in 2021, then plummeted by 127.66% to -$2.8 million in 2022, then plummeted by 1412.95% to -$41.8 million in 2023, then soared by 67.46% to -$13.6 million in 2024, then dropped by 14.02% to -$15.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$15.5 million in Q4 2025, -$7.6 million in Q3 2025, and -$9.1 million in Q2 2025.